Duarte, CA, United States of America

Indu Nair

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Indu Nair: Innovator in Pancreatic Beta Cell Viability

Introduction

Indu Nair is a notable inventor based in Duarte, California, recognized for his contributions to the field of medical science, particularly in improving pancreatic beta cell viability. With a focus on innovative methods and compositions, Nair has made significant strides in treating diseases related to beta cell destruction.

Latest Patents

Indu Nair holds 2 patents that showcase his groundbreaking work. His latest patents include methods, compositions, and kits aimed at enhancing pancreatic beta cell viability and addressing conditions such as type 1 diabetes mellitus. The patents detail novel approaches for delivering RLIP76 polypeptides or GSTA4 polypeptides to islets, which are crucial for increasing beta-cell viability. Additionally, these patents provide methods for treating diseases by transplanting islets into subjects, thereby offering potential solutions for managing diabetes and related conditions.

Career Highlights

Nair is affiliated with City of Hope, a prominent research and treatment center. His work at this institution has allowed him to focus on innovative research that has the potential to transform diabetes treatment. His dedication to advancing medical science is evident in his patent filings and ongoing research efforts.

Collaborations

Indu Nair collaborates with esteemed colleagues such as Sanjay Awasthi and Sushma Yadav, who contribute to his research endeavors. Their combined expertise enhances the potential for impactful discoveries in the field of diabetes treatment.

Conclusion

Indu Nair's innovative work in improving pancreatic beta cell viability positions him as a key figure in medical research. His patents and collaborations reflect a commitment to advancing treatment options for diabetes and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…